Vaxcyte, Inc. (PCVX) Makes Strides on Pneumonia Treatment, Plots Coverage Extension

1 day ago 6

Abdul Rahman

Thu, December 11, 2025 astatine 10:23 AM CST 2 min read

Vaxcyte, Inc. (NASDAQ:PCVX) is one of the champion biotech stocks to buy, according to Wall Street analysts. On December 8, the institution confirmed the dosing of the archetypal patients successful its Phase 3 OPUS trial. The institution is evaluating VAX-31 successful the prevention of invasive pneumococcal illness and pneumonia successful adults. It plans to enroll 4,000 participants successful consultation with the US Food and Drug Administration.

Vaxcyte, Inc. (PCVX) Makes Strides connected Pneumonia Treatment, Plots Coverage Extension

Topline information and tolerability results from the proceedings should service arsenic the ground for VAX-31 Biologics License Application successful the 4th fourth of adjacent year. The institution is gathering connected VAX-31 Phase ½ studies that showed some broader serotype sum and stronger wide immune responses than Prevnar 20 (PCV20).

“On the spot of the unprecedented results from our VAX-31 Phase 1/2 survey successful adults and our carrier-sparing platform, we are uniquely positioned to acceptable a caller modular by which aboriginal big pneumococcal vaccines volition beryllium measured. Through this program, we are aiming to grow the breadth of illness and serotype sum portion ensuring immunogenicity levels stay precocious to guarantee durable protection,” said Grant Pickering, Chief Executive Officer and Co-founder of Vaxcyte.

On November 19, analysts astatine Leerink Partners raised the stock’s terms people to $77 from $60 portion reiterating an Outperform rating. The affirmative stance echoes the probe firm’s assurance astir the company’s optimized VAX-31 pneumococcal conjugate vaccine dose. With GSK and Pfizer disclosing issues with their pneumococcal conjugate vaccine programs, the probe steadfast sees tremendous marketplace imaginable for VAX-31.

Vaxcyte, Inc. (NASDAQ:PCVX) is simply a clinical-stage vaccine institution focused connected processing vaccines to combat superior bacterial infections similar pneumococcal disease, Group A Strep, and Shigella. It leverages precocious cell-free exertion to make analyzable proteins for amended immune responses, with cardinal candidates similar VAX-31 and VAX-24 successful precocious objective trials for infants and adults.

While we admit the imaginable of PCVX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Best Consumer Goods Stocks Billionaires Are Quietly Buying and Goldman Sachs Penny Stocks: Top 12 Stock Picks.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.